163 related articles for article (PubMed ID: 38595736)
1. Evaluation of salivary tumor necrosis factor
Abdul Aziz Shaikh S; Denny E C; Kumarchandra R; Natarajan S; Sunny J; Shenoy N; K P N
Front Oral Health; 2024; 5():1375162. PubMed ID: 38595736
[TBL] [Abstract][Full Text] [Related]
2. Alpha-L-fucosidase levels in patients with oral submucous fibrosis and controls: A comparative study.
Suresh H; Gunasekaran N; James A; Krishnan R; Thayalan DK; Kumar AR
J Oral Maxillofac Pathol; 2022; 26(4):594. PubMed ID: 37082061
[TBL] [Abstract][Full Text] [Related]
3. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
Nandakumar A; Nataraj P; James A; Krishnan R; K M M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
[TBL] [Abstract][Full Text] [Related]
4. Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Indian J Dent Res; 2022; 33(3):272-276. PubMed ID: 36656187
[TBL] [Abstract][Full Text] [Related]
5. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
7. Expression of Salivary miRNA 21 in Oral Submucous Fibrosis (OSMF): An Observational Study.
Prasad SR; Pai A; Shyamala K; Yaji A
Microrna; 2020; 9(4):295-302. PubMed ID: 31985389
[TBL] [Abstract][Full Text] [Related]
8. 8-Isoprostane: A salivary oxidative stress biomarker for oral submucous fibrosis and oral squamous cell carcinoma.
Meera S; Sarangarajan R; Rajkumar K
J Oral Maxillofac Pathol; 2020; 24(2):279-284. PubMed ID: 33456237
[TBL] [Abstract][Full Text] [Related]
9. Salivary malondialdehyde in oral submucous fibrosis - A marker for oxidative damage.
Ganta SR; Chittemsetti S; Sravya T; Guttikonda VR
J Oral Maxillofac Pathol; 2021; 25(1):82-87. PubMed ID: 34349416
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of myofibroblasts in oral submucous fibrosis and oral squamous cell carcinoma: The pathogenesis and correlation.
Gandhi P; Prasad UC
Dent Res J (Isfahan); 2017; 14(5):314-320. PubMed ID: 29109745
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 as Potential Biomarker in Oral Submucous Fibrosis: An Immunohistochemical Study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
J Microsc Ultrastruct; 2023; 11(2):75-80. PubMed ID: 37448822
[TBL] [Abstract][Full Text] [Related]
12. Expression of salivary levels of S100A7 in oral submucous fibrosis and oral leukoplakia.
Fathima R; Ramamoorthi R; Gopalakrishnan S; Jayaseelan VP; Muniapillai S
J Oral Maxillofac Pathol; 2024; 28(1):84-89. PubMed ID: 38800445
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of trace elements in the saliva and serum of patients with oral submucous fibrosis and squamous cell carcinoma.
Kumar V; Kumari N; Ealla KKR; Gour S; Srivastava H; Rallabhandi S
Mol Clin Oncol; 2024 Mar; 20(3):18. PubMed ID: 38332992
[TBL] [Abstract][Full Text] [Related]
14. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
[TBL] [Abstract][Full Text] [Related]
15. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
16. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
17. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
18. Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.
Panda A; Behura SS; Bhuyan L; Dash KC; Kumar V; Mukherjee S
J Oral Maxillofac Pathol; 2020; 24(1):183. PubMed ID: 32508472
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
20. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]